Suppr超能文献

血液透析患者骨矿物质密度与骨转换生化标志物之间的关系

Relationship between bone mineral density and biochemical markers of bone turnover in hemodialysis patients.

作者信息

Sit Dede, Kadiroglu Ali Kemal, Kayabasi Hasan, Atay A Engin, Yilmaz Zulfukar, Yilmaz M Emin

机构信息

Department of Nephrology, Dicle University Medical Faculty, Diyarbakir, Turkey.

出版信息

Adv Ther. 2007 Sep-Oct;24(5):987-95. doi: 10.1007/BF02877703.

Abstract

End-stage renal disease is closely associated with changes in bone and mineral metabolism. In recent times, osteoporosis has become important among hemodialysis (HD) patients. In this study, the investigators sought to evaluate the relationship between bone mineral density (BMD) and biochemical markers of bone turnover among HD patients. A total of 70 uremic patients on a maintenance HD program for at least 1 y were enrolled in the study. All patients were treated with conventional bicarbonated HD for 5 h through the use of low-flux hollow-fiber dialyzers. Bone densitometry was measured by dual energy x-ray absorptiometry in the lumbar spine (LS) and the femoral neck (FN). BMD was classified according to World Health Organization criteria on the basis of BMD T scores. Biochemical bone turnover markers such as calcium, phosphorus, ionized calcium, intact parathyroid hormone, alkaline phosphatase, plasma bicarbonate, blood pH, serum albumin, and hematocrit levels were measured before the HD session in the morning. Male patients (n=37; 52.9%; mean age, 46.2+/-17.0 y) were assigned to a single study group, and female patients (n=33; 47.1%; mean age, 44.0+/-13.1 y) to another. Mean duration of HD treatment was 33.7+/-28.5 mo in females and 33.0+/-26.0 mo in males. Among all patients, BMD T scores in the osteopenia/osteoporosis range were observed at the LS in 58 patients (82.8%) and at the FN in 45 patients (64.3%). According to BMD measurements in FN T score, 10% of patients (n=7) were osteoporotic, 54.3% (n=38), osteopenic, and 35.7% (n=25), normal. On the other hand, in LS T score, the results were 47.1% (n=33) osteoporotic, 35.7% (n=25), osteopenic, and 17.1% (n=12), normal. No statistically significant association was found in osteopenia/osteoporosis between sexes according to FN and LS T score (P=.542, P=.267, respectively). No significant relationship was noted between BMD and biochemical markers of bone turnover. A positive correlation was found between FN T scores of BMD and age (r=.413, P=.000). BMD T scores within the range of scores for osteopenia/osteoporosis were observed in 78.5% of patients at the LS and in 58.5% of patients at the FN. The investigators concluded that no correlation could be found between markers of bone turnover and bone mass measurements in both skeletal regions. LS T score results were worse than FN T score results. Elevated alkaline phosphastase levels combined with high intact parathyroid hormone levels are predictive of renal osteodystrophy but not of adynamic bone disease/osteoporosis.

摘要

终末期肾病与骨矿物质代谢变化密切相关。近年来,骨质疏松症在血液透析(HD)患者中变得愈发重要。在本研究中,研究人员试图评估HD患者的骨密度(BMD)与骨转换生化标志物之间的关系。共有70例接受维持性HD治疗至少1年的尿毒症患者纳入本研究。所有患者均使用低通量中空纤维透析器,通过常规碳酸氢盐HD治疗5小时。采用双能X线吸收法测量腰椎(LS)和股骨颈(FN)的骨密度。根据世界卫生组织标准,基于BMD T值对BMD进行分类。在上午HD治疗前测量生化骨转换标志物,如钙、磷、离子钙、完整甲状旁腺激素、碱性磷酸酶、血浆碳酸氢盐、血液pH值、血清白蛋白和血细胞比容水平。男性患者(n = 37;52.9%;平均年龄,46.2±17.0岁)被分配到一个研究组,女性患者(n = 33;47.1%;平均年龄,44.0±13.1岁)被分配到另一个研究组。女性HD治疗的平均持续时间为33.7±28.5个月,男性为33.0±26.0个月。在所有患者中,58例(82.8%)患者的LS处观察到骨量减少/骨质疏松范围内的BMD T值,45例(64.3%)患者的FN处观察到该值。根据FN T值的BMD测量结果,10%的患者(n = 7)为骨质疏松症,54.3%(n = 38)为骨量减少,35.7%(n = 25)为正常。另一方面,在LS T值中,结果为47.(n = 33)为骨质疏松症,35.7%(n = 25)为骨量减少,17.1%(n = 12)为正常。根据FN和LS T值,在骨量减少/骨质疏松方面未发现性别之间存在统计学显著关联(分别为P = 0.542,P = 0.267)。未发现BMD与骨转换生化标志物之间存在显著关系。发现BMD的FN T值与年龄之间存在正相关(r = 0.413,P = 0.000)。78.5%的患者在LS处和58.5%的患者在FN处观察到骨量减少/骨质疏松范围内的BMD T值。研究人员得出结论,在两个骨骼区域中,骨转换标志物与骨量测量之间均未发现相关性。LS T值结果比FN T值结果更差。碱性磷酸酶水平升高与高完整甲状旁腺激素水平相结合可预测肾性骨营养不良,但不能预测动力缺失性骨病/骨质疏松症。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验